ARTICLE | Company News
Galenica submits European application for PA21
December 21, 2012 2:06 AM UTC
Galenica Ltd. (SIX:GALN) submitted a regulatory application to EMA for PA21 to treat hyperphosphatemia in patients with chronic kidney disease (CKD). The oral iron-based phosphate binder is being deve...